Dose Optimization for Anticancer Drug Combinations: Maximizing Therapeutic Index via Clinical Exposure-Toxicity/Preclinical Exposure-Efficacy Modeling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose Optimization for Anticancer Drug Combinations: Maximizing Therapeutic Index via Clinical Exposure-Toxicity/Preclinical Exposure-Efficacy Modeling

Published:2019-07-18 Issue:22 Volume:25 Page:6633-6643
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Bottino Dean C.,Patel Mayankbhai,Kadakia Ekta,Zhou Jilai,Patel Chirag,Neuwirth Rachel,Iartchouk Natasha,Brake Rachael,Venkatakrishnan Karthik,Chakravarty Arijit

Funder

Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential;Molecules;2024-09-09

2. Use of Drug Sensitisers to Improve Therapeutic Index in Cancer;Pharmaceutics;2024-07-11

3. The Herbal Combination Shu Gan Jie Yu Regulates the SNCG/ER-a/AKT-ERK Pathway in DMBA-Induced Breast Cancer and Breast Cancer Cell Lines Based on RNA-Seq and IPA Analysis;Integrative Cancer Therapies;2024-01

4. Serabelisib regulates GSDMD-mediated pyroptosis, apoptosis and migration of hepatoma cells via the PI3K/Akt/E-cadherin signaling pathway;Advances in Clinical and Experimental Medicine;2023-07-24

5. Model-based assessment of combination therapies – ranking of radiosensitizing agents in oncology;BMC Cancer;2023-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP